Viewing Study NCT06647732


Ignite Creation Date: 2025-12-24 @ 9:55 PM
Ignite Modification Date: 2026-01-10 @ 5:08 PM
Study NCT ID: NCT06647732
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2024-10-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib Plus Rituximab As Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module